VANCOUVER, B.C., Oct. 14, 2025 (GLOBE NEWSWIRE) -- via IBN - Fairchild Gold Corp. (“Fairchild” or the “Company”) (TSXV: FAIR), is pleased to announce a non-brokered private placement financing (the “Offering”). The fully committed placement, the majority of which is being subscribed by a European Strategic Investor, is expected to close on or about October 17, 2025, subject to customary regulatory approvals. The Offering will consist of up to 12,222,222 units (the “Units”) at a price of C$0.09 per Unit, for ...

融资方案概要 - 因投资者需求强劲，公司宣布将非经纪私募配售规模上调至最多19,142,858个单位，每个单位定价0.35加元，募集资金总额为670万加元 [1] - 每个单位包含一股普通股和半份普通股认购权证，每份完整权证可在24个月内以0.50加元的价格认购一股额外普通股 [1] - 此次配售发行的所有证券将设有自发行之日起四个月的禁售期 [1] 资金用途与安排 - 配售所得净收益将用于勘探支出、营运资金、矿区付款以及完成战略合作伙伴交易的过渡资金 [2] - 可能就部分配售支付介绍人费用，包括6%的现金和6%的不可转让介绍人权证，该权证可在24个月内以0.35加元的价格行使 [2] - 配售预计于2025年10月24日左右完成，最终需获得多伦多证券交易所创业板批准 [3] 公司业务背景 - Intrepid Metals Corp 是一家加拿大公司，专注于在美国亚利桑那州东南部成熟的矿业管辖区勘探高品位关键金属，如铜、银和锌矿项目 [5] - 公司已收购或协议收购多个已备钻项目，包括Corral铜矿项目、Tombstone South项目以及Mesa Well项目 [5] - 公司股票在多伦多证券交易所创业板和OTCQB风险市场交易，代码分别为"INTR"和"IMTCF" [5]

Oracle Commodity Holding Corp. has increased its non-brokered private placement from 7.5 million units to 8 million units due to high demand, raising potential gross proceeds to $280,000.Company insiders will subscribe for up to 1.75 million units, contributing up to $61,250.The proceeds will be used for general corporate purposes and to acquire a 2% royalty from U.S. Fluorspar LLC, aiming to strengthen the company's position in the mining royalty sector.Oracle Commodity Holding Corp. is a mining royalty co ...

融资核心信息 - 公司宣布与新的医疗健康领域机构投资者签订证券购买协议，总融资额最高可达1.045亿美元，包括1650万美元的初始前期资金以及投资者选择行使认股权证后可追加的8800万美元 [1] - 此次私募配售的定价较公司前一日收盘价存在溢价 [1] - 融资包括发行1,993,940股美国存托凭证及可认购最多7,975,760股美国存托凭证的认股权证，组合购买价格为每股8.25美元 [3] - 私募配售预计于2025年10月14日左右完成，需满足惯例交割条件 [4] 投资者与承销商 - 参与融资的投资者包括AIGH Capital Management、Soleus Capital、Nantahala Capital、Diadema Partners、Stonepine Capital Management、ADAR1 Capital Management和Velan Capital等多家领先的医疗健康机构投资者 [1][2] - Maxim Group LLC在此次私募配售中担任独家配售代理 [2] 认股权证条款 - 认股权证分为四个系列，每个系列均可认购最多1,993,940股美国存托凭证 [5] - H系列认股权证行权价为每股9.075美元，总行权金额最高达1810万美元，行权期与公司获得FDA关于QRX003的Type C会议纪要相关 [5] - I系列认股权证行权价为每股10.3125美元，总行权金额最高达2060万美元，行权期与QRX003单药和辅助关键试验达到主要终点相关 [5] - J系列和K系列认股权证行权价均为每股12.375美元，总行权金额各最高达2470万美元，J系列行权期与获得FDA批准相关，K系列行权期与公司出售优先审评券相关 [5] - 所有认股权证均可立即行权，并在特定事件发生后30天或发行日起五年内到期 [5] 资金用途与公司前景 - 公司计划将私募配售的前期净收益用于一般公司用途，包括运营费用、研发、完成QRX003用于Netherton综合征的临床开发、营运资金、未来收购及一般资本支出 [6] - 假设所有认股权证均以现金行权，总净收益预计足以支持公司运营至2027年 [6] 公司业务概览 - 公司是一家专注于罕见病和孤儿药的后期临床阶段专业制药公司 [9] - 公司的创新研发管线包含三种在研产品，潜在适应症包括Netherton综合征、剥脱性皮肤综合征、SAM综合征等多种罕见病 [9]

Vancouver, British Columbia – October 9, 2025 – TheNewswire - Adamera Minerals Corp. (TSX-V: ADZ; OTC: DDNFF) ("Adamera" or the "Company") is pleased to announce a non-brokered private placement financing to raise gross proceeds of up to $724,000 through the issuance of both Share Units and Flow-Through Share Units. The financing will fund near-term exploration drilling on the Company’s Flag Hill South gold and silver property in Washington State project. In addition, it will fund on-going systematic explo ...

私募融资完成情况 - 公司已完成非经纪私募发行的第一轮融资 共发行13,500,000个单位 每单位价格为0.10加元 融资总额为1,350,000加元 [1] - 每个单位包含一股普通股和半份可转让普通股认股权证 每份完整认股权证可于2027年10月7日前以每股0.20加元的价格认购一股额外普通股 [1] - 一位战略投资者在第一轮融资中认购了3,500,000个单位 并预计在获得TSX-V批准后于第二轮认购剩余的1,500,000个单位 [2] 融资相关费用与条款 - 公司就第一轮私募支付了33,775加元的中介费 并发行了337,750份中介认股权证 每份认股权证可于2027年10月7日前以每股0.20加元的价格购买一股普通股 [2] - 此次私募发行的证券受四个月禁售期限制 该禁售期将于2026年2月8日到期 [3] 内部人士参与情况 - 公司控制人Lions Bay Capital Inc 认购了3,325,000个单位 该交易构成关联方交易 [4] - 此次向关联方发行股份豁免了MI 61-101的估值要求和少数股东批准要求 因为发行给关联方的证券对价公允价值未超过公司市值的25% [4] 资金用途与公司战略 - 融资净收益将用于推进公司在秘鲁的勘探和社区关系项目 以及公司营运资金用途 [5] - 公司致力于构建高品质矿业资产组合 重点目标为大型铜矿和金矿 其最先进的项目是位于秘鲁北部的Las Huaquillas金铜银项目 [8] - 公司计划通过增值收购机会性地扩大项目组合 并由经验丰富的管理团队和专注于长期价值构建的投资者支持 [8][9]

TORONTO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (TSXV: QGR) (“Q-Gold” or the “Company”) is pleased to announce that it has closed its previously announced private placement offering of subscription receipts (each, a “Subscription Receipt”). Pursuant to an agency agreement dated October 3, 2025 (the "Agency Agreement") between the Company and BMO Capital Markets, as agent (the "Agent"), the Company issued a total 76,666,667 Subscription Receipts at a price of $0.15 per Subscription Receipt f ...

Vancouver, British Columbia and Boise, Idaho--(Newsfile Corp. - October 3, 2025) - Thunder Mountain Gold, Inc. (TSXV: THM) (OTCQB: THMG) (the "Company" or "Thunder Mountain") is issuing this news release in order to clarify that the private placement announced in its news release disseminated earlier today (the "Original News Release") is for an aggregate of up to 10,000,000 units of the Company (each, a "Unit") at a price of US$0.25 (CAD$0.35) per Unit for gross proceeds of up to US$2,500,000 (CAD$3,500,0 ...

VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Mirasol Resources Ltd. (TSX-V: MRZ) (OTC: MRZLF) (the “Company” or “Mirasol”) today announced it is arranging a non-brokered private placement financing (the “Offering”) of up to 6,666,667 Units (the “Units”) at a price of $0.45 per Unit for aggregate gross proceeds of $3.0 million. Each Unit will be comprised of one (1) common share and one-half of one (1/2) non-transferable common share purchase warrant (the “Warrant”), with each whole Warrant ...

K9 Gold Corp. Announces Financing, Marketing Agreement and Progress on Trinity Silver ProjectOctober 02, 2025 8:00 AM EDT | Source: K9 Gold Corp.West Vancouver, British Columbia--(Newsfile Corp. - October 2, 2025) - K9 Gold Corp. (TSXV: KNC) (OTCQB: WDFCF) (FSE: 5GP0) ("K9" or the "Company") is pleased to announce a non-brokered private placement financing (the "Private Placement") of up to 10,000,000 units at a price of $0.25 per unit, for total gross proceeds of up to $2,500,000. Each unit w ...